Lipophilic statins inhibit Zika virus production in Vero cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Espano, Erica | - |
dc.contributor.author | Nam, Jeong-Hyun | - |
dc.contributor.author | Song, Eun-Jung | - |
dc.contributor.author | Song, Daesub | - |
dc.contributor.author | Lee, Chong-Kil | - |
dc.contributor.author | Kim, Jeong-Ki | - |
dc.date.accessioned | 2021-09-01T09:38:49Z | - |
dc.date.available | 2021-09-01T09:38:49Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2019-08-07 | - |
dc.identifier.issn | 2045-2322 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/63550 | - |
dc.description.abstract | Zika virus (ZIKV) is a mosquito-borne member of the Flaviviridae family. ZIKV infection has been associated with neurological complications such as microcephaly in newborns and Guillain-Barre syndrome in adults; thus, therapeutic agents are urgently needed. Statins are clinically approved for lowering cholesterol levels to prevent cardiovascular disease but have shown potential as antiviral drugs. In this study, we explored the possibility of utilizing statins as anti-ZIKV drugs. We found that, generally, lipophilic statins (atorvastatin, cerivastatin, fluvastatin, lovastatin, mevastatin, and simvastatin) could reduce ZIKV production in vitro and result in smaller foci of infection. Time-of-drug-addition assay revealed that early treatment with statins is more beneficial than late treatment; however, statins could not completely inhibit the entry stage of ZIKV infection. Furthermore, individual lipophilic statins differed in anti-ZIKV capacity, with fluvastatin being the most efficient at low concentrations. Taken together, this study shows that statins or their derivatives have the potential to be used as anti-ZIKV therapeutic agents. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | NATURE RESEARCH | - |
dc.subject | ENTRY | - |
dc.subject | INFECTION | - |
dc.subject | DENGUE | - |
dc.subject | SIMVASTATIN | - |
dc.subject | LIPIDS | - |
dc.subject | DRUG | - |
dc.title | Lipophilic statins inhibit Zika virus production in Vero cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Song, Daesub | - |
dc.contributor.affiliatedAuthor | Kim, Jeong-Ki | - |
dc.identifier.doi | 10.1038/s41598-019-47956-1 | - |
dc.identifier.scopusid | 2-s2.0-85070512288 | - |
dc.identifier.wosid | 000479030000033 | - |
dc.identifier.bibliographicCitation | SCIENTIFIC REPORTS, v.9 | - |
dc.relation.isPartOf | SCIENTIFIC REPORTS | - |
dc.citation.title | SCIENTIFIC REPORTS | - |
dc.citation.volume | 9 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.subject.keywordPlus | ENTRY | - |
dc.subject.keywordPlus | INFECTION | - |
dc.subject.keywordPlus | DENGUE | - |
dc.subject.keywordPlus | SIMVASTATIN | - |
dc.subject.keywordPlus | LIPIDS | - |
dc.subject.keywordPlus | DRUG | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.